Structural Formula (Pemetrexed 01)
Pemetrexed Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0504
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Pemetrexed (NDC 67184-0504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pemetrexed 02)
This text contains a graph showing the Overall Sunvival (%) for different treatment arms over time in months, with the number of people at risk in each arm. The treatment arms are P+P4C, P4C, and P+C, which involve different combinations of Pemetrexed for Injection, pembrolizumab, and platinum chemotherapy, with or without placebo.*
Figure 2 (Pemetrexed 03)
This is a survival probability chart for two different chemotherapy treatments (Pemetrexed + Cisplatin and Gemcitabine + Cisplatin). The chart shows the number of patients at risk (12, 15, 18, 21, 2, 2) and their survival time in months. The data is split into two groups with corresponding curves representing the probability of survival over time for each treatment.*
Figure 3 (Pemetrexed 04)
This is a survival probability table comparing the effectiveness of two treatments, Pemetrexed+Cisplatin (PC) and Gomcitabine+Cisplatin (GC), over a period of 27 months. The table shows the survival time (in months) of patients receiving each treatment and the number of patients at risk for each time interval.*
Figure 4 (Pemetrexed 05)
Figure 5 (Pemetrexed 06)
Figure 6 (Pemetrexed 07)
This is a graph displaying the survival probability of patients who were given Pemetrexed versus those who received a placebo. The number of patients at risk is shown for each treatment group. The X-axis represents time in months, while the Y-axis represents the probability of survival. However, the graph is incomplete and some of the text is unreadable.*
Figure 7 (Pemetrexed 08)
This is a survival analysis table that shows the survival probability, patients at risk, and survival time (in months) for patients who were given either pemetrexed or placebo. It includes the number of patients at risk at specific points in time and the number of patients who survived. However, the output contains errors and unreadable characters, making the data unclear.*
Figure 8 (Pemetrexed 09)
This is a survival probability chart that compares the effectiveness of Pemetrexed and placebo for an unknown medical condition. The chart displays the number of patients at risk for each treatment group over time, as well as their survival time in months. There is not enough information to determine the exact medical condition being studied or to draw any conclusions about the effectiveness of these treatments.*
Figure 9 (Pemetrexed 10)
This appears to be a table displaying survival time in months for patients at risk who were given Pemetrexed + Cisplatin treatment. The table shows different time periods and the number of patients at risk for each period. It appears to be related to medical research.*
Package Carton – Pemetrexed For Injection 100 mg Single-dose Vial (Pemetrexed 11)
This text describes a medication called Pemetrexed. It is available in 100 mg vials for injection and is labeled as USP for injection.*
Package Carton – Pemetrexed For Injection 500 mg Single-dose Vial (Pemetrexed 12)
This is a product description of Pemetrexed for Injection, USP, available in vials of 500 mg. It is intended for intravenous use only and is a prescription-only medication. There are warnings on the label cautioning that it is a potent drug and should only be used under the guidance of a healthcare professional. The first few lines of the text may be a product code or reference number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
